European Boutiques and Mid-Market Specialists. To navigate this highly fragmented and clinically complex market, a distinct group of boutique investment banks has carved out highly defensible advisory positions. The following table profiles the leading specialist boutiques, tech-focused powerhouses, and mid-market global connectors active across the European HealthTech, MedTech and Healthcare AI sectors.

The European digital health and healthcare technology (HealthTech) landscape is undergoing a profound structural transformation, transitioning from an era of speculative, growth-at-all-costs capital deployment to a disciplined, metric-driven environment focused on unit economics, clinical utility, and artificial intelligence integration. While global bulge-bracket institutions continue to dominate mega-cap transactions, a highly specialised tier of boutique investment banks h

The European healthcare technology and medical technology sectors have transitioned into a period of disciplined industrial maturity. The speculative, venture-subsidised fragmentation of the early 2020s has given way to a transactional ecosystem where strategic value is defined by clinical utility, regulatory resilience, and technological defensibility. This maturation has driven a corresponding transformation in mergers and acquisitions advisory. This shift has reopened the